EU Suspends Ulipristal Pending Further Review

Action Prompted By Another Case Of Serious Liver Injury

 
• By Ian Schofield
  
Folders_Risk_Assessment
Ulipristal is being scrutinized over the risk of liver damage • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation